ASK4PHARMA CONSULTING

Active

Private limited companyfounded 2020active for 6 yearsBrugstraat(STE) 65, 9190 Stekene, BelgiumKBO/BCE: BE 0744.703.246

From the official registers: KBO 5 annual accounts at the National Bank publications in the Belgian Official Gazette

Summary

ASK4PHARMA CONSULTING has been active since 2020 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €1.5m and a net result of €386,067. Equity is growing by about 35% per year across the filed financial years. Its solvency ranks better than 92% of 9,643 sector peers (NACE 82, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).

Risk analysisFollow Report Compare

ASK4PHARMA CONSULTINGActiveChecked score 96/100

Risk analysis Report Compare

Official details

KBO

Status: Active since 04-03-2020 Normal situation
Legal form: Private limited company
Registered office: Brugstraat(STE) 65, 9190 Stekene
Activity: Other business support services NACE 82990
Establishment unit: 2.299.921.765 9190 Stekene, since 04-03-2020
Financial year end: 31 December
Peppol: Reachable since 30-09-2025

Company details

Who decides

Board

Smet AnnDirector · since 03-03-2020
Strobbe KoenraadDirector · since 03-03-2020

Board & ownership

How it is doing

96 Excellent Checked score 2025

Bankruptcy probabilitywithin 12 months: < 0.1%

Annual accounts 2025

Gross margin: €479,328; ▲ 7.7%
Turnover: ≈ €720,000; estimated
Profit: €386,067; ▲ 27.5%
Equity: €1.5m; ▲ 31.7%
Total assets: €1.6m; ▲ 30.2%

2025 accounts filed 28 days late

Filed on 28-08-2026at the National Bank

Financials

Why 96lowers riskSize: total assets €1.6mSector: Office administrative, office support and other business support activities (NACE 82)Figures for financial year 2025 (filed 28-08-2026)Equity €1.5m (92.7% of total assets)Show the evidence

Checked score

Score 2025

96 / 100

Excellent

Probability in this band: under 0.55%

Financially better than 71% of its sector peers (NACE 82, micro)

Every signal that counts is listed under Signals.

Financial strength · tick = 2024

Strong

Solvency 100=

equity 92.7% of total assets

Liquidity 57-1

short-term debt 7.0% · cash 5.6%

Profitability 99=

return on assets 24.0%

Bankruptcy probability, 12 months

< 0.1% Very low

0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.2% (12,668 companies, NACE 82, micro)

Last 24 months 11-2024: < 0.1% 12-2024: < 0.1%● unchanged vs 11-2024 01-2025: < 0.1%● unchanged vs 12-2024lowest value 02-2025: < 0.1%● unchanged vs 01-2025 03-2025: < 0.1%● unchanged vs 02-2025 04-2025: < 0.1%● unchanged vs 03-2025 05-2025: < 0.1%● unchanged vs 04-2025 06-2025: < 0.1%● unchanged vs 05-2025 07-2025: 0.1%▲ +0.1 percentage points vs 06-2025 08-2025: 0.1%● unchanged vs 07-2025 09-2025: < 0.1%▼ -0.1 percentage points vs 08-2025 10-2025: < 0.1%● unchanged vs 09-2025 11-2025: < 0.1%● unchanged vs 10-2025 12-2025: < 0.1%● unchanged vs 11-2025 01-2026: < 0.1%● unchanged vs 12-2025 02-2026: < 0.1%● unchanged vs 01-2026 03-2026: < 0.1%● unchanged vs 02-2026 04-2026: < 0.1%● unchanged vs 03-2026 05-2026: 0.1%▲ +0.1 percentage points vs 04-2026 06-2026: 0.1%● unchanged vs 05-2026 07-2026: 0.1%● unchanged vs 06-2026 08-2026: 0.2%▲ +0.1 percentage points vs 07-2026highest value 09-2026: < 0.1%▼ -0.2 percentage points vs 08-2026 10-2026: < 0.1%● unchanged vs 09-2026

Credit of up to €140,000 on 30-day terms is acceptable

Liquidity ample (current ratio 13.9, compared with 12.18 in 2024, above the usual 1.5; short-term debt: 7% and cash: 5.6% of total assets), and 7.3% of the assets are financed with debt and provisions.

How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100	Excellent	under 0.55%
60-74	Healthy	0.55% to 1.5%
45-59	Fair	1.5% to 4.2%
25-44	Weak	4.2% to 15.0%
0-24	Critical	over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 82, micro): better than 88% on solvency, 51% on liquidity, 73% on profitability and 73% on growth.

The bankruptcy probability was computed on 31-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Five signals.

lowers riskraises risk

Size: total assets €1.6m

Companies of this size fail less often; how much that weighs depends on the rest of its profile.

NBB · annual accounts

Sector: Office administrative, office support and other business support activities (NACE 82)

KBO

Figures for financial year 2025 (filed 28-08-2026)

NBB · annual accounts

Equity €1.5m (92.7% of total assets)

NBB · annual accounts

2025 accounts filed 28 days late

The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 28-08-2026, 28 days later. Nearly half (47%) of Belgian companies file late; of those that file 1 to 90 days late, 2.0% are now bankrupt, dissolved or in another special legal status, against 1.66% of all filers. A delay like this does not count in the score.

NBB · 5 filings

Deviation from the deadline

2025

28 days late

2024

18 days late

2023

7 days early

2022

41 days early

2021

52 days early

← before the deadline after the deadline →

tick = median of all Belgian filingsring = median in the sector

This company filed its last 5 accounts on average 11 days before the deadline; the sector median (NACE 82) for financial year 2024 is 7 days before the deadline, and 35% of those companies filed late.

Searched, nothing found (2)

Next filing not due yet

The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 25 July (4 of the last 5 filed years within 35 days of that day).

Companies Code · seven months

Where today falls in the filing period

01-11-2026 today31-12-2026 year end31-07-2027 deadline

No strike-offs in the KBO publications

Searched since 2021.

KBO publications · our coverage

Key points

Positive: Among the best 5% on net resultsector median €16,314 · 9,639 companies €386,067 View
Positive: 5 profitable years in a rowprofit 2025: €386,067 5 years View
Positive: Equity rose in 2025from €1.1m to €1.5m ▲ 31.7% View

Documents

Key facts about ASK4PHARMA CONSULTING

What is the company number of ASK4PHARMA CONSULTING?: 0744.703.246. In Belgium the VAT number is the company number with BE in front: BE 0744.703.246.
Where is ASK4PHARMA CONSULTING based?: The registered office is at Brugstraat(STE) 65, 9190 Stekene.Company details
What does ASK4PHARMA CONSULTING do?: According to the KBO register, the main activity is other business support services (NACE 82990).
What is the legal form of ASK4PHARMA CONSULTING?: Private limited company (BV).
When was ASK4PHARMA CONSULTING founded?: On 04-03-2020.
Is ASK4PHARMA CONSULTING still active?: Yes, ASK4PHARMA CONSULTING is an active enterprise in the KBO register.
What is the turnover of ASK4PHARMA CONSULTING?: ≈ €720,000 in financial year 2025. Estimated from the gross margin of €479,328: probably between €590,000 and €1.0m, based on 33 comparable companies, NACE 82990.Financials
Is ASK4PHARMA CONSULTING profitable?: In financial year 2025, ASK4PHARMA CONSULTING made a profit of €386,067.
Where can I find the annual accounts of ASK4PHARMA CONSULTING?: ASK4PHARMA CONSULTING filed 5 annual accounts with the National Bank of Belgium, the latest for financial year 2025.Annual accounts at the National Bank
When are the next annual accounts of ASK4PHARMA CONSULTING due?: By 31-07-2027, for financial year 2026.Timeline